Halozyme Therapeutics (HALO) Shares Outstanding (Diluted) (2010 - 2026)
Halozyme Therapeutics' Shares Outstanding (Diluted) was 121.22 million in Q2 2026, down 2.4% from 124.16 million a year earlier and down 1.4% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Halozyme Therapeutics came in at 123.9 million, down 4.3% from FY2024.
- Shares Outstanding (Diluted) has now declined for four consecutive years, with a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 129.42 million in FY2024 (-3.6%), 134.2 million in FY2023 (-4.6%), 140.61 million in FY2022 (-4.2%) and 146.8 million in FY2021 (+3.8%).
- The Q2 2026 figure marks the lowest quarterly Shares Outstanding (Diluted) since Q1 2014.
- Compared with a year earlier, Shares Outstanding (Diluted) has declined for 18 straight quarters, with an average decline of 3.5% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q4 2021 (growth of 3.8%); the worst was Q1 2024 (a decline of 6.5%).
- Per Business Quant data, HALO's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 122.88 million (Q1 2026), 123.9 million (Q4 2025) and 122.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 121.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121.22 Mn |
| Mar 31, 2026 | 122.88 Mn |
| Dec 31, 2025 | 123.90 Mn |
| Sep 30, 2025 | 122.33 Mn |
| Jun 30, 2025 | 124.16 Mn |
| Mar 31, 2025 | 126.64 Mn |
| Dec 31, 2024 | 129.42 Mn |
| Sep 30, 2024 | 130.13 Mn |
| Jun 30, 2024 | 129.22 Mn |
| Mar 31, 2024 | 128.89 Mn |
| Dec 31, 2023 | 134.20 Mn |
| Sep 30, 2023 | 134.08 Mn |
| Jun 30, 2023 | 133.54 Mn |
| Mar 31, 2023 | 137.90 Mn |
| Dec 31, 2022 | 140.61 Mn |
| Sep 30, 2022 | 139.39 Mn |
| Jun 30, 2022 | 142.22 Mn |
| Mar 31, 2022 | 141.28 Mn |
| Dec 31, 2021 | 146.80 Mn |
| Sep 30, 2021 | 146.69 Mn |
API Access
Halozyme Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();